Clinical features and pathological findings by liver biopsy in patients with immune-related sclerosing cholangitis induced by immune checkpoint inhibitors
Digestive and Liver Disease · 2025
DOI: 10.1016/j.dld.2025.01.037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive and Liver Disease, 2025. Verfasst von Tsukasa Yasuda und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, 65 Tsuruma-Cho, Showa-Ku, Nagoya, Aichi 466-8550, Japan. Hauptthemen laut MEDLINE: Cholangitis, Sclerosing, Immune Checkpoint Inhibitors, Liver, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Center for Global Health and Medicine.
Abstract (Originalsprache)
BACKGROUND: Immune-related sclerosing cholangitis (irSC) induced by immune checkpoint inhibitors (ICIs) is relatively rare, and its clinical and pathological features are not well known. AIMS: We aimed to compare the clinical course and pathological findings of irSC with those of non-irSC liver injury. METHODS: Clinical data were retrospectively collected from 2416 patients with advanced malignancies treated with ICIs between September 2014 and October 2023. The data of patients with severe ICI-induced liver injury who underwent liver biopsy were analyzed and compared between patients with irSC and non-irSC. RESULTS: Ninety-three (3.8 %) patients had severe ICI-induced liver injury, and 38 underwent liver biopsy. Of these, five were diagnosed with irSC. The irSC group had a significantly longer time to onset of ICI-induced liver injury and a lower rate of improvement of liver injury than did the non-irSC group (irSC, 3/5; non-irSC, 32/33). Liver biopsies revealed more moderate-to-severe pathological cholangitis in the irSC group than in the non-irSC group (irSC, n = 5/5; non-irSC, n = 16/33). Other pathological findings were similar between the two groups. CONCLUSION: Appropriate management of irSC requires an understanding of its characteristics of late onset and steroid resistance, and liver biopsy, in addition to imaging, may be useful for diagnosing irSC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, 65 Tsuruma-Cho, Showa-Ku, Nagoya, Aichi 466-8550, Japan.
- Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, 65 Tsuruma-Cho, Showa-Ku, Nagoya, Aichi 466-8550, Japan. Electronic address: tahkun56@gmail.com.
- Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, 65 Tsuruma-Cho, Showa-Ku, Nagoya, Aichi 466-8550, Japan.
- Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, 4-86 Minaminokawa, Ogaki, Gifu 503-8502, Japan.
- Department of Pathology and Clinical Laboratories, Nagoya University Hospital, 65 Tsuruma-Cho, Showa-Ku, Nagoya, Aichi 466-8550, Japan.
Förderung
- National Center for Global Health and Medicine
Zitieren
APA
Yasuda, T., Ito, T., Ishikawa, T., Mizuno, K., Yamamoto, T., Yokoyama, S., Yamamoto, K., Imai, N., Ishizu, Y., Honda, T., Koshiyama, Y., Yasuda, S., Toyoda, H., Ando, Y., Shimoyama, Y., & Kawashima, H. (2025). Clinical features and pathological findings by liver biopsy in patients with immune-related sclerosing cholangitis induced by immune checkpoint inhibitors. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2025.01.037
Vancouver
Yasuda T, Ito T, Ishikawa T, Mizuno K, Yamamoto T, Yokoyama S, et al. Clinical features and pathological findings by liver biopsy in patients with immune-related sclerosing cholangitis induced by immune checkpoint inhibitors. Digestive and Liver Disease. 2025. doi:10.1016/j.dld.2025.01.037
BibTeX
@article{Yasuda2025,
author = {Yasuda, Tsukasa and Ito, Takanori and Ishikawa, Takuya and Mizuno, Kazuyuki and Yamamoto, Takafumi and Yokoyama, Shinya and Yamamoto, Kenta and Imai, Norihiro and Ishizu, Yoji and Honda, Takashi and Koshiyama, Yuichi and Yasuda, Satoshi and Toyoda, Hidenori and Ando, Yuichi and Shimoyama, Yoshie and Kawashima, Hiroki},
title = {Clinical features and pathological findings by liver biopsy in patients with immune-related sclerosing cholangitis induced by immune checkpoint inhibitors},
journal = {Digestive and Liver Disease},
year = {2025},
doi = {10.1016/j.dld.2025.01.037}
}
EUVIMED